# Oui Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oui-therapeutics

- Industry: Healthcare
- Headquarters: New Haven, US
- Website: www.ouitherapeutics.com
- Total disclosed funding: $11M
- Latest round: Series A (Aug 2, 2022)
- Investors on record: 5

## About

Based in Connecticut, US, and founded in 2017, Oui Therapeutics, Inc. operates as a provider of a digital therapy platform. In August 2022, the firm raised USD 11 million in series A funding co-led by investors Athyrium Capital Management, CVS Health Ventures, and Otsuka Pharmaceutical Co., Ltd.

The business provides a digital therapy platform with a focus on mental health businesses, suicide prevention, and delivery paradigms for both private and public use.

## Funding rounds

- Series A, Aug 2, 2022, $11M — First Round Capital, Athyrium Capital Management, Otsuka Pharmaceutical Co., Ltd., CVS Health Ventures
- Seed, Jan 1, 2019 — Flare Capital Partners

## Investors

- Flare Capital Partners (https://capitalatlas.ai/funds/flare-capital-partners) — Seed
- First Round Capital (https://capitalatlas.ai/funds/first-round-capital) — Series A
- Athyrium Capital Management (https://capitalatlas.ai/funds/athyrium-capital-management) — Series A
- Otsuka Pharmaceutical Co., Ltd. — Series A
- CVS Health Ventures (https://capitalatlas.ai/funds/cvs-health-ventures) — Series A